Wikidata

(Q61909295)

English

An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema

clinical trial

In more languages

Statements

short name
APREMINUM (English)
0 references
title
An Investigator-initiated, Randomized, Double-blind, Placebo Controlled Study of Apremilast to Demonstrate Efficacy in Subjects With Nummular Eczema (English)
0 references
medical condition
eczema
0 references
dermatitis
0 references
country
Germany
0 references
start time
5 July 2017
0 references
end time
December 2019
0 references
number of participants
40
0 references
research intervention
apremilast
0 references
thalidomide
0 references
minimum age
18 year
0 references
maximum age
85 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61909295&oldid=2109304786"